TrialEpilepsia2020

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.

Michael R Sperling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.